Diao, X.; Luo, D.; Wang, D.; Lai, J.; Li, Q.; Zhang, P.; Huang, H.; Wu, L.; Lu, S.; Hu, S.
Lurasidone versus Quetiapine for Cognitive Impairments in Young Patients with Bipolar Depression: A Randomized, Controlled Study. Pharmaceuticals 2022, 15, 1403.
https://doi.org/10.3390/ph15111403
AMA Style
Diao X, Luo D, Wang D, Lai J, Li Q, Zhang P, Huang H, Wu L, Lu S, Hu S.
Lurasidone versus Quetiapine for Cognitive Impairments in Young Patients with Bipolar Depression: A Randomized, Controlled Study. Pharmaceuticals. 2022; 15(11):1403.
https://doi.org/10.3390/ph15111403
Chicago/Turabian Style
Diao, Xiangyuan, Dan Luo, Dandan Wang, Jianbo Lai, Qunxiao Li, Peifen Zhang, Huimin Huang, Lingling Wu, Shaojia Lu, and Shaohua Hu.
2022. "Lurasidone versus Quetiapine for Cognitive Impairments in Young Patients with Bipolar Depression: A Randomized, Controlled Study" Pharmaceuticals 15, no. 11: 1403.
https://doi.org/10.3390/ph15111403
APA Style
Diao, X., Luo, D., Wang, D., Lai, J., Li, Q., Zhang, P., Huang, H., Wu, L., Lu, S., & Hu, S.
(2022). Lurasidone versus Quetiapine for Cognitive Impairments in Young Patients with Bipolar Depression: A Randomized, Controlled Study. Pharmaceuticals, 15(11), 1403.
https://doi.org/10.3390/ph15111403